21 . September , 2018 - Friday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Orphenadrine injection

Big Image
Generic Name: Orphenadrine citrate
Dosage Form: Injection

Rx ONLY

Orphenadrine Description

Orphenadrine citrate is the citrate salt of Orphenadrine N,N-dimethyl-2-[(o-methyl-α-phenylbenzyl)oxy]-ethylamine citrate (1:1). It occurs as a white, crystalline powder having a bitter taste. It is practically odorless; sparingly soluble in water, slightly soluble in alcohol.

Each vial contains 60 mg of Orphenadrine citrate in aqueous solution. Each vial also contains: sodium metabisulfite, 2 mg; sodium chloride, 5.8 mg; sodium hydroxide, to adjust pH; and water for injection, q.s. to 2 mL. The structural formula is:

Molecular Formula: C18H23NO•C6H8O7 M.W.: 461.50

Orphenadrine - Clinical Pharmacology

The mode of therapeutic action has not been clearly identified, but may be related to its analgesic properties. Orphenadrine citrate also possesses anti-cholinergic actions.

Indications and Usage for Orphenadrine

Orphenadrine citrate is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. The mode of action of the drug has not been clearly identified, but may be related to its analgesic properties. Orphenadrine citrate does not directly relax tense skeletal muscles in man.

Contraindications

Contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardio-spasm (megaesophagus) and myasthenia gravis.

Contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

Warnings

Some patients may experience transient episodes of light-headedness, dizziness or syncope. Orphenadrine citrate may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; ambulatory patients should therefore be cautioned accordingly.

Orphenadrine citrate injection contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than nonasthmatic people.

Precautions

Confusion, anxiety and tremors have been reported in few patients receiving propoxyphene and Orphenadrine concomitantly. As these symptoms may be simply due to an additive effect, reduction of dosage and/or discontinuation of one or both agents is recommended in such cases.

Orphenadrine citrate should be used with caution in patients with tachycardia, cardiac decompensation, coronary insufficiency, cardiac arrhythmias.

Safety of continuous long-term therapy with Orphenadrine has not been established. Therefore, if Orphenadrine is prescribed for prolonged use, periodic monitoring of blood, urine and liver function values is recommended.

Pregnancy

Teratogenic Effects; Pregnancy Category C

Safe use of Orphenadrine has not been established with respect to adverse effects upon fetal development. Therefore, Orphenadrine should be used in women of childbearing potential and particularly during early pregnancy only when in the judgment of the physician the potential benefits outweigh the possible hazards.

Pediatric Use

Safety and effectiveness in children have not been established; therefore, this drug is not recommended for use in the pediatric age group.

Adverse Reactions

Adverse reactions of Orphenadrine are mainly due to the mild anti-cholinergic action of Orphenadrine, and are usually associated with higher dosage. Dryness of the mouth is usually the first adverse effect to appear. When the daily dose is increased, possible adverse effects include: tachycardia, palpitation, urinary hesitancy or retention, blurred vision, dilatation of pupils, increased ocular tension, weakness, nausea, vomiting, headache, dizziness, constipation, drowsiness, hypersensitivity reactions, pruritus, hallucinations, agitation, tremor, gastric irritation, and rarely urticaria and other dermatoses. Infrequently, an elderly patient may experience some degree of mental confusion. These adverse reactions can usually be eliminated by reduction in dosage. Very rare cases of aplastic anemia associated with the use of Orphenadrine tablets have been reported. No causal relationship has been established.

Rare instances of anaphylactic reaction have been reported associated with the intramuscular injection of Orphenadrine citrate.

Orphenadrine Dosage and Administration

Adults - One 2 mL vial (60 mg) intravenously or intramuscularly; may be repeated every 12 hours. Relief may be maintained by one (100 mg) Orphenadrine citrate tablet twice daily.

Parenteral drug products should be inspected visually for particulate matter, whenever solution and container permit.

How is Orphenadrine Supplied

Orphenadrine Citrate Injection USP is supplied as follows: Cartons of 10 (NDC 55390-059-10) 2 mL vials, each vial containing 60 mg of Orphenadrine citrate in aqueous solution.

Store at controlled room temperature 15° to 30°C (59° to 86°F). [See USP.] Protect from light.

Single dose vial. Discard unused portion.

Manufactured by:                                                 Manufactured for:

Ben Venue Laboratories, Inc.                                Bedford Laboratories™

Bedford, OH 44146                                               Bedford, OH 44146

September 2004                                                   Div - ORP - P01


Orphenadrine citrate (Orphenadrine citrate)
PRODUCT INFO
Product Code 55390-059 Dosage Form INJECTION
Route Of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Orphenadrine citrate (Orphenadrine) Active 60 MILLIGRAM  In 2 MILLILITER
sodium chloride Inactive  
sodium hydroxide Inactive  
sodium metabisulfite Inactive  
water Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 55390-059-10 10 VIAL In 1 BOX contains a VIAL
1 2 MILLILITER In 1 VIAL This package is contained within the BOX (55390-059-10)

Revised: 10/2006

Recent Drug Updates at DrugIndexOnline:





Almotriptan Almotriptan
Some commonly used brand names are: In the U.S.— Axert Category Antimigraine agent Description Almotriptan ( al-moh-TRIP-tan) is used to treat severe migraine headaches. Many people find that their headaches go away completely after they take almotriptan. Other people find that t more...

Ascorbic Acid Solution Ascorbic Acid Solution
Generic Name: Ascorbic Acid (Vitamin C) Solution, Liquid, and Syrup (ASS-kor-bik ASS-id) Brand Name: Cecon and ProtexinAscorbic Acid Solution is used for:Treating and preventing low levels of vitamin C. It may also be used for other conditions as determined by your doctor. Ascorbic Acid Solutio more...

Avinza Extended-Release Capsules Avinza Extended-Release Capsules
Generic Name: Morphine Extended-Release Capsules (MORE-feen) Brand Name: AvinzaAvinza Extended-Release Capsules is an extended-release form of morphine that is normally taken only once a day. It should only be used for moderate to severe pain that requires continuous, around-the-clock treatment more...

diphenhydramine and pseudoephedrine diphenhydramine and pseudoephedrine
Generic Name: diphenhydramine and pseudoephedrine (dye fen HYE dra meen/ soo doe e FED rin) Brand Names: Actifed Allergy Day/Night, Benadryl Allergy Decongestant, Benylin Multi-Symptom What is diphenhydramine and pseudoephedrine? Diphenhydramine is an antihistamine that reduces the natur more...

Etodolac Tablets Etodolac Tablets
Dosage Form: Tablets BOXED WARNING Cardiovascular Risk NSAIDs11 may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction (MI), and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors more...

Guaifenesin AC Liquid Guaifenesin AC Liquid
Generic Name: codeine and guaifenesin (KO deen and gwye FEN a sin) Brand Names: Bitex Liquid, Brontex, Cheracol with Codeine, Cheratussin AC, Codafen, Glydeine, Guaiatussin AC, Guaifen AC, Guaifen-C, Guaifenesin AC Liquid, Guiatuss AC, Guiatussin with Codeine, Halotussin AC, Iophen-C NR, more...

Indocid Ophthalmic Indocid Ophthalmic
Some commonly used brand names are: In the U.S.— Ocufen 2 Profenal 4 Voltaren Ophthalmic 1 In Canada— Indocid 3 Ocufen 2 Voltaren Ophtha 1 Another commonly used name for indomethacin is indometacin . Note: For quick reference, the following nonsteroidal anti-inflammatory dru more...

Menadiol Menadiol
Some commonly used brand names are: In the U.S.— AquaMEPHYTON 2 Mephyton 2 Note: For quick reference, the following medicines are numbered to match the corresponding brand names. Other commonly used names are: phylloquinone , phytomenadione , vitamin K 1 , and vitamin K 4 . Thi more...